All News
Filter News
Found 808,961 articles
-
AAOMS, Henry Schein Cares Foundation present grants to OMS volunteers
1/15/2019
The American Association of Oral and Maxillofacial Surgeons (AAOMS) and the Henry Schein Cares Foundation are supporting the volunteerism of four oral and maxillofacial surgeons (OMSs) through the joint Global Outreach Program
-
Because of the government shutdown, which as of Monday, January 14 is into its fourth week, 40 percent of the U.S. FDA employees were furloughed. However, the two approvals described here should still be on track.
-
After four years at AstraZeneca, Chief Medical Officer Sean Bohen will be leaving the company following an organizational shakeup at the U.K.-based pharma giant. Bohen joined AstraZeneca from Genentech in 2015 and also serves as head of global medicines development.
-
CRISPR, aging, food health, artificial intelligence and more will be some of the key areas of conversation for the coming year, researchers say.
-
“Think of it as an installment plan that’s then tied to how well the therapy works,” Mark Trusheim, strategic director of the MIT Center for Biomedical Innovation’s NEWDIGS program, told Business Insider. “This would be a car loan but you’ve still got to see if the car is going to work.”
-
The U.S. Food and Drug Administration (FDA) approved Bridgewater, NJ-based Amneal Pharmaceuticals’ generic version of Novartis’ Exelon Patch (Rivastigmine Transdermal System) for dementia related to Alzheimer’s and Parkinson’s diseases.
-
Artificial intelligence technology has an established home in drug design for many developers. Now, researchers are seeing it as a potential tool in driving therapeutic choices in the treatment of ovarian cancer.
-
The Orphan Drug Act (ODA) was enacted on January 4, 1983. It was designed to encourage the development of drugs for rare diseases. The law was amended the following year to define rare diseases as ones that affect fewer than 200,000 people in the U.S. But it also included drugs that affect more t...
-
Aslan Pharmaceuticals’ first-line therapy for HER1/HER2 co-expressing cancer tumors failed to meet primary endpoints in a mid-stage trial after 12 weeks of treatment, the company announced Sunday.
-
Despite the government shutdown, at least two biotech companies, Kaleido Biosciences and Cirius Therapeutics, have filed with the U.S. Securities and Exchange Commission (SEC) for initial public offerings (IPO).
-
Why are some people enthusiastic about going to work in the morning, while others are miserable? Is it the person or is it the job? Many people haven’t stopped to consider if they might be contributing to their own unhappiness at work.
-
For the First Time, We're More Likely to Die From Accidental Opioid Overdose Than Motor Vehicle Crash
1/14/2019
National Safety Council analysis reveals trends that worsen the odds of dying accidentally
-
Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases
1/14/2019
Ascletis Pharma Inc. and Suzhou Alphamab Co., Ltd. jointly announce today that Ascletis' subsidiary and Alphamab have entered into a strategic collaboration and exclusive licensing agreement for anti-PD-L1 KN035 to treat hepatitis B and other viral diseases in Greater China
-
ROBOCATH’S R-ONE™ ROBOT ACQUIRED BY THE MEDICAL TRAINING & TESTING CENTER IN ROUEN FOR FUTURE HEALTHCARE PRACTITIONER TRAINING
1/14/2019
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that the Medical Training and Testing Center (MTC) in Rouen will use its R-One™ robot for future training. Founded in 2017, the MTC is a new center dedicated to training healthcare professionals in a number specialties, with special focus on new technologies.
-
USANA-sponsored The Dr. Oz Show now officially distributed in China
1/14/2019
Aofei Media now distributes new episodes of The Dr. Oz Show in China with Chinese subtitles. On December 25, 2018 it became available on digital platforms including Youku, Tencent Penguin, iQiyi, Sohu Video and Sina Weibo.
-
New York Gov. Cuomo Proposes Bold Steps to Reduce Youth Tobacco Use, Including Raising Tobacco Sale Age to 21
1/14/2019
New York Gov. Andrew Cuomo has shown great leadership in proposing strong steps to further drive down tobacco use and reverse the youth e-cigarette epidemic, including raising the tobacco sale age to 21 and prohibiting tobacco sales in pharmacies statewide
-
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
1/14/2019
Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:NVCN) announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq Capital Market.
-
High-Tech Cannabis Campus Planned For New York State
1/14/2019
Flora California Prime Inc. (Flora), a San Diego-based cannabis company focused on the health and wellness space with existing operations throughout California and offices in Buffalo, has been approved to acquire 47 useable acres at the Buffalo Lakeside Commerce Park from the Buffalo Urban Development Corp., making it one of the largest of its kinds in the nation.
-
Top International Cannabis Industry Leaders to Convene at the CannaTech House in Davos, Switzerland
1/14/2019
The world's top cannabis industry leaders will convene in an unprecedented gathering in Davos, Switzerland from January 22-25.
-
National Partners in Healthcare Partners With National Medical Billing Management
1/14/2019
National Partners in Healthcare (NPH), a national healthcare organization delivering best in class anesthesiology services, announced today that National Medical Billing Management (NMBM) has partnered with NPH.